GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Veerhealth Care Ltd

Veerhealth Care wins Rs. 6.15 Crores skincare order from FMCG leader

ORDERS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 17 Apr 2026, 05:20 PM IST  ·  BSE ID: b163c2e1-50fa-4fda-8515-1f5cf905b9a5
View Original BSE Filing (PDF)
💡
In Simple Terms
A skincare company just won a Rs. 6.15 Crores contract from a major FMCG firm to supply face care products within 45 days.
🤖 AI Summary
  • Veerhealth Care secured Rs. 6.15 Crores skincare order from unnamed FMCG leader
  • Order for face care products, execution deadline 45 days from award
  • Domestic contract with no promoter group or related-party involvement
  • Third material order win in 27 days — demonstrates accelerating business momentum
🔢 Key Numbers — exact figures from BSE filing, not rounded
Order value (excluding GST)
Rs. 6.15 Crores
Execution timeline
45 days
Order classification
Domestic supply
Three orders in 27 days total
Rs. 7.75 Crores
🏢 How This Affects the Company
📈
Business Impact
Order represents material new revenue contribution. Combined with Rs. 5.50 Crores order (March 20) and Rs. 150 lakhs export order (April 11), demonstrates expanding order book and market traction in skincare segment.
💰
Financial Impact
Rs. 6.15 Crores order (excluding GST) will contribute to Q4 FY26 and FY27 revenue. 45-day execution timeline indicates cash realization within near term.
⚙️
Operational Impact
45-day execution window requires focused production and supply chain coordination for face care products. Manufacturing capacity and timeline adherence critical given recent order volume acceleration.
⚠️
Risk Impact
Client confidentiality prevents independent verification of FMCG partner. Concentration of three major orders in 27 days creates near-term execution risk if any order faces delivery delays or quality issues.
👥 What This Means For Shareholders
✅
Action Required
No action required. Order filing is informational disclosure under Regulation 30.
👤
Who Is Affected
All equity shareholders benefit from order contribution to FY26-27 revenue pipeline. Earnings visibility improves with three orders totaling Rs. 7.75 Crores within 27 days.
🔍
Management Signal
Management is actively winning FMCG sector contracts, indicating successful market penetration and product-market fit in face care segment.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q4 FY26 results — verify Rs. 6.15 Crores order recognized in revenue or pipeline
May 2026 filing — track execution status and client retention for repeat orders
FY27 Q1 results — confirm order completion and assess new FMCG contract pipeline
MEDIUM RISK Client confidentiality prevents independent credit verification. Rapid order concentration in 27 days creates short-term execution and quality assurance risks.
💡 Investor Takeaway
Veerhealth Care secured Rs. 6.15 Crores in face care products order from FMCG leader, to be executed in 45 days. This is the third major order in 27 days (total Rs. 7.75 Crores), signaling accelerating demand. Client identity confidential. No related-party involvement confirmed.
⚖️ Strengths & Concerns

✅ Positives

  • Order win follows Rs. 5.50 Crores domestic and Rs. 150 lakhs export orders within 27 days, confirming market demand
  • FMCG sector client represents stable recurring revenue opportunity in face care products segment

⚠️ Concerns

  • Client identity withheld per confidentiality clause — prevents stakeholder verification of partner creditworthiness
  • Rapid order concentration (Rs. 6.15 Cr + Rs. 5.50 Cr + Rs. 1.5 Cr in 27 days) creates execution risk within short timeframes
📅 Company Track Record
Veerhealth Care won Rs. 5.50 Crores from major FMCG company (March 20, 2026), representing 76% of Q3 FY26 revenue. April 11 filing disclosed Rs. 150 lakhs New York export order. Three major orders totaling Rs. 7.75 Crores secured within 27 days indicates accelerating business momentum post-Q3.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.